Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 14 | 2022 | 301 | 3.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 592 | 1.830 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 198 | 1.710 |
Why?
|
| Monocytes | 3 | 2022 | 258 | 1.010 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 29 | 0.950 |
Why?
|
| Immunity | 1 | 2021 | 51 | 0.800 |
Why?
|
| Obesity | 3 | 2024 | 965 | 0.760 |
Why?
|
| Genetic Markers | 1 | 2019 | 118 | 0.680 |
Why?
|
| Cytosine | 2 | 2016 | 33 | 0.660 |
Why?
|
| Insulin Resistance | 1 | 2019 | 177 | 0.610 |
Why?
|
| Central Nervous System | 1 | 2016 | 130 | 0.540 |
Why?
|
| Humans | 29 | 2024 | 34853 | 0.540 |
Why?
|
| Health Status Disparities | 1 | 2021 | 583 | 0.530 |
Why?
|
| Semiconductors | 1 | 2015 | 10 | 0.520 |
Why?
|
| Diet | 1 | 2021 | 747 | 0.520 |
Why?
|
| Genome | 2 | 2015 | 117 | 0.520 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 455 | 0.500 |
Why?
|
| Hawaii | 5 | 2023 | 1878 | 0.490 |
Why?
|
| HIV Infections | 2 | 2019 | 2207 | 0.490 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 6 | 0.480 |
Why?
|
| Exons | 1 | 2013 | 80 | 0.460 |
Why?
|
| Alternative Splicing | 1 | 2013 | 82 | 0.460 |
Why?
|
| CpG Islands | 6 | 2019 | 91 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 484 | 0.410 |
Why?
|
| Genome-Wide Association Study | 4 | 2020 | 271 | 0.400 |
Why?
|
| Conserved Sequence | 2 | 2010 | 106 | 0.390 |
Why?
|
| Genome, Human | 2 | 2013 | 112 | 0.390 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2010 | 11 | 0.390 |
Why?
|
| Histones | 4 | 2013 | 177 | 0.380 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 968 | 0.350 |
Why?
|
| Organ Specificity | 3 | 2016 | 123 | 0.250 |
Why?
|
| HCT116 Cells | 2 | 2015 | 34 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2021 | 371 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 338 | 0.230 |
Why?
|
| Brain | 1 | 2010 | 1268 | 0.220 |
Why?
|
| Food | 1 | 2023 | 95 | 0.220 |
Why?
|
| Food Supply | 1 | 2023 | 99 | 0.210 |
Why?
|
| Vaccines | 1 | 2022 | 49 | 0.210 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 6 | 0.210 |
Why?
|
| Dietary Fiber | 1 | 2021 | 42 | 0.200 |
Why?
|
| Middle Aged | 6 | 2021 | 9642 | 0.200 |
Why?
|
| Cell Line | 4 | 2013 | 1289 | 0.200 |
Why?
|
| Disease Progression | 1 | 2024 | 580 | 0.200 |
Why?
|
| Simvastatin | 1 | 2021 | 28 | 0.200 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 35 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 224 | 0.200 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 841 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 528 | 0.190 |
Why?
|
| Lyases | 1 | 2021 | 51 | 0.190 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 120 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2022 | 628 | 0.180 |
Why?
|
| Social Support | 1 | 2022 | 356 | 0.180 |
Why?
|
| Neuroglia | 1 | 2020 | 117 | 0.180 |
Why?
|
| Animals | 11 | 2021 | 14307 | 0.180 |
Why?
|
| Male | 9 | 2021 | 18870 | 0.170 |
Why?
|
| Selenoproteins | 1 | 2021 | 151 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 257 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2022 | 1353 | 0.170 |
Why?
|
| Gene Silencing | 3 | 2010 | 143 | 0.170 |
Why?
|
| Parkinson Disease | 1 | 2020 | 167 | 0.170 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 115 | 0.170 |
Why?
|
| Liver | 1 | 2021 | 447 | 0.170 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 125 | 0.170 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 2 | 0.160 |
Why?
|
| Inflammation | 1 | 2022 | 577 | 0.160 |
Why?
|
| Triglycerides | 1 | 2018 | 129 | 0.160 |
Why?
|
| Adolescent | 3 | 2023 | 5035 | 0.160 |
Why?
|
| Mice | 9 | 2021 | 5668 | 0.150 |
Why?
|
| Female | 8 | 2021 | 19873 | 0.150 |
Why?
|
| Oligodendroglioma | 2 | 2008 | 5 | 0.150 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 4 | 0.150 |
Why?
|
| Logistic Models | 1 | 2019 | 894 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1056 | 0.140 |
Why?
|
| HIV | 1 | 2016 | 97 | 0.140 |
Why?
|
| Chromatin | 3 | 2013 | 164 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2010 | 287 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 105 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 92 | 0.140 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 64 | 0.130 |
Why?
|
| DNA Replication | 2 | 2013 | 148 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 638 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 298 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2015 | 36 | 0.130 |
Why?
|
| Self Care | 1 | 2015 | 150 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2013 | 309 | 0.120 |
Why?
|
| Adult | 4 | 2022 | 11034 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2013 | 7 | 0.120 |
Why?
|
| Phenotype | 2 | 2018 | 650 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2013 | 27 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 292 | 0.110 |
Why?
|
| Aged | 3 | 2020 | 6448 | 0.100 |
Why?
|
| Smoking | 1 | 2018 | 903 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 1023 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2011 | 40 | 0.100 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 10 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2010 | 49 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2021 | 897 | 0.090 |
Why?
|
| Reference Values | 1 | 2010 | 204 | 0.090 |
Why?
|
| Japan | 2 | 2021 | 296 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2010 | 73 | 0.090 |
Why?
|
| Environment | 1 | 2010 | 130 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2008 | 49 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 550 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1300 | 0.080 |
Why?
|
| Cadherins | 1 | 2007 | 82 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2022 | 1318 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1530 | 0.070 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 13 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2005 | 13 | 0.070 |
Why?
|
| Cation Transport Proteins | 1 | 2005 | 30 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 58 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 106 | 0.060 |
Why?
|
| Gene Expression | 2 | 2008 | 639 | 0.060 |
Why?
|
| Camptothecin | 1 | 2003 | 20 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2008 | 386 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2022 | 23 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 25 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 71 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 15 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2003 | 107 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2022 | 80 | 0.050 |
Why?
|
| Philippines | 1 | 2021 | 72 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 37 | 0.050 |
Why?
|
| Creatinine | 1 | 2021 | 101 | 0.050 |
Why?
|
| Neurons | 1 | 2008 | 1130 | 0.050 |
Why?
|
| Glutathione Peroxidase | 1 | 2021 | 109 | 0.050 |
Why?
|
| United States | 2 | 2022 | 3894 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 132 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2021 | 213 | 0.040 |
Why?
|
| Selenium | 1 | 2021 | 144 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 871 | 0.040 |
Why?
|
| Grooming | 1 | 2018 | 4 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 468 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1014 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2018 | 37 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 50 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 600 | 0.040 |
Why?
|
| Social Behavior | 1 | 2018 | 124 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 198 | 0.040 |
Why?
|
| Ectoderm | 1 | 2016 | 11 | 0.040 |
Why?
|
| Neural Tube | 1 | 2016 | 7 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 18 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2018 | 304 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 1503 | 0.040 |
Why?
|
| Body Size | 1 | 2016 | 28 | 0.040 |
Why?
|
| Homozygote | 1 | 2016 | 75 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2022 | 1961 | 0.030 |
Why?
|
| Nicotine | 1 | 2018 | 238 | 0.030 |
Why?
|
| Point Mutation | 1 | 2016 | 88 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 53 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 608 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1317 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 152 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 874 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2007 | 781 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2008 | 420 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 480 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 154 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 794 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 229 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2333 | 0.030 |
Why?
|
| RNA | 1 | 2016 | 234 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 283 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 171 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 292 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 1422 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1349 | 0.030 |
Why?
|
| Replication Origin | 1 | 2013 | 14 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 25 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2013 | 34 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2013 | 12 | 0.030 |
Why?
|
| S Phase | 1 | 2013 | 36 | 0.030 |
Why?
|
| Methylation | 1 | 2013 | 102 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2013 | 26 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 41 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2013 | 56 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 642 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 605 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 522 | 0.030 |
Why?
|
| Telomere | 1 | 2013 | 51 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 348 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 4012 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 2011 | 66 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2016 | 653 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2875 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 201 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 2128 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 406 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 74 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 496 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2007 | 84 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 188 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 490 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 8 | 0.020 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2005 | 9 | 0.020 |
Why?
|
| Retroviridae | 1 | 2005 | 22 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 430 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 69 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 562 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 932 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2005 | 154 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1490 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 18 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 608 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 171 | 0.010 |
Why?
|
| Computers | 1 | 2002 | 27 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 392 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 209 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 396 | 0.010 |
Why?
|
| Software | 1 | 2002 | 204 | 0.010 |
Why?
|
| Computational Biology | 1 | 2002 | 275 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1152 | 0.010 |
Why?
|